IS POSTTX DSA (DONOR-SPECIFIC ANTIBODIES), IN PATIENTS WHO SURVIVE THE FIRST 6 MONTHS, DELETERIOUS TO THE LONG-TERM? OUTCOME? A FIVE-YEAR ANALYSIS.: 1855

C. G. Ventura,P. S. Souza,H. Rodrigues,N. Panajotopoulos,G. Preuhs,F. C. Lemos,F. Agena,L. M. Fadel,K. M. Takaki,R. Rocha,W. C. Nahas,J. E. Kalil-Filho,M. C. R. Castro,E. David-Neto

Transplantation（2010）

Cited 0|Views22

No score

Abstract

Ventura, C. G.1; Souza, P. S.1; Rodrigues, H.2; Panajotopoulos, N.2; Preuhs, G.2; Lemos, F. C.1; Agena, F.1; Fadel, L. M.1; Takaki, K. M.1; Rocha, R.1; Nahas, W. C.1; Kalil-Filho, J. E.2; Castro, M. C.R.1; David-Neto, E.3 Author Information

Translated text

Key words

posttx dsa,antibodies,donor-specific,long-term,five-year

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined